James Chen-tson Fang

James Chen-tson Fang's AcademicInfluence.com Rankings

Medical

#2621

World Rank

#3052

Historical Rank

Cardiology

#244

World Rank

#250

Historical Rank

medical Degrees

James Chen-tson Fang

Philosophy

#7537

World Rank

#10765

Historical Rank

Logic

#4587

World Rank

#5898

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

James Chen-tson Fang's Degrees

Doctorate Medicine Harvard University
PhD Cardiology Stanford University

Why Is James Chen-tson Fang Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James Chen-tson Fang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (4204)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (2552)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (1864)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (1334)
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa (2016) (866)
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. (2007) (826)
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. (2003) (599)
2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (485)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
Endothelium-Derived Nitric Oxide Regulates Arterial Elasticity in Human Arteries In Vivo (2001) (389)
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. (2010) (358)
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure (2011) (339)
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials (2004) (277)
Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. (2015) (272)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. (2020) (266)
Recognition and Initial Management of Fulminant Myocarditis (2020) (262)
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial (2002) (257)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. (2012) (236)
Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. (2011) (227)
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. (2022) (225)
Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association. (2012) (219)
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. (2012) (218)
Expression of the Chemokine Receptor CXCR3 and Its Ligand IP-10 During Human Cardiac Allograft Rejection (2001) (214)
Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction: Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial (2014) (213)
Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes (2014) (211)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2019) (198)
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction (2016) (196)
Multiple Biomarkers for Risk Prediction in Chronic Heart Failure (2012) (195)
The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. (2008) (178)
Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. (2013) (175)
Cardiac allograft vasculopathy (2000) (172)
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. (2003) (164)
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. (2005) (162)
Rise of the machines--left ventricular assist devices as permanent therapy for advanced heart failure. (2009) (133)
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. (2011) (133)
Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. (2009) (125)
Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. (2016) (120)
Bridging Anticoagulation: Primum Non Nocere. (2015) (109)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. (2020) (101)
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. (2012) (100)
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. (2008) (100)
Gastrointestinal and Liver Issues in Heart Failure (2016) (99)
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. (2004) (98)
Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation (2011) (96)
Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes (2018) (95)
Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure (2009) (94)
Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. (2016) (91)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
The frailty syndrome and outcomes in the TOPCAT trial (2018) (90)
Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. (2019) (79)
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) (2017) (79)
Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart (2016) (79)
Strain Improves Risk Prediction Beyond Ejection Fraction in Chronic Systolic Heart Failure (2014) (77)
Effect of Antihypertensive Therapy on Incident Stroke in Cohorts With Prehypertensive Blood Pressure Levels: A Meta-Analysis of Randomized Controlled Trials (2012) (76)
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial☆ (2002) (73)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
Clinical Predictors of Hepatic Fibrosis in Chronic Advanced Heart Failure (2010) (71)
Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. (2006) (70)
Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials (2011) (68)
Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. (2019) (67)
EXPRESSION PATTERNS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN HUMAN CARDIAC ALLOGRAFTS: ASSOCIATION WITH REJECTION (2003) (67)
The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. (2011) (65)
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial (2016) (65)
Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. (2014) (64)
Acute decompensated heart failure: update on new and emerging evidence and directions for future research. (2013) (64)
Plasma α-Tocopherol and Coronary Endothelium-Dependent Vasodilator Function (1999) (61)
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial. (2018) (56)
Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. (2016) (56)
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. (2012) (56)
Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation (2002) (53)
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma (2017) (52)
Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial. (2018) (52)
Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. (2017) (51)
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. (2011) (50)
Effect of Ejection Fraction on Clinical Outcomes in Patients treated with Omecamtiv Mecarbil in GALACTIC-HF. (2021) (49)
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. (2019) (48)
Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. (2008) (48)
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial. (2022) (47)
Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm? (2011) (46)
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials (2020) (44)
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. (2005) (44)
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure. (2016) (44)
Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. (2016) (43)
Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction. (2019) (42)
In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. (2006) (42)
Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. (2009) (42)
Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation. (2004) (40)
EVIDENCE OF GLYCOLYSIS UPREGULATION AND PYRUVATE MITOCHONDRIAL OXIDATION MISMATCH DURING MECHANICAL UNLOADING OF THE FAILING HUMAN HEART: IMPLICATIONS FOR CARDIAC RELOADING AND CONDITIONING (2016) (40)
Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee. (2015) (37)
Heart Failure With Preserved Ejection Fraction: A Kidney Disorder? (2016) (36)
Underestimating medical therapy for coronary disease... again. (2011) (35)
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial (2018) (34)
The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure (2020) (34)
Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT (2019) (33)
Intensity and focus of heart failure disease management after hospital discharge. (2005) (33)
Pharmacologic therapies for acute cardiogenic shock (2014) (33)
Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions. (2002) (32)
DNA Methylation Reprograms Cardiac Metabolic Gene Expression in End-Stage Human Heart Failure. (2019) (32)
Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT (2018) (32)
Development and Implementation of a Comprehensive, Multidisciplinary Emergency Department Extracorporeal Membrane Oxygenation Program (2017) (31)
Dietary sodium adherence is poor in chronic heart failure patients. (2015) (31)
Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study. (2017) (31)
SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease (2017) (31)
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial (2018) (31)
Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support: The Utah Bleeding Risk Score (2018) (30)
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure (2020) (29)
Remote ischemic preconditioning in patients undergoing cardiovascular surgery: Evidence from a meta-analysis of randomized controlled trials. (2016) (29)
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure (2020) (27)
Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support (2018) (27)
2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. (2016) (26)
Team-based Care for Advanced Heart Failure. (2015) (26)
Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure. (2002) (24)
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial (2018) (23)
Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study (2017) (23)
Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first? (2005) (23)
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma (2018) (22)
BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis. (2006) (22)
Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis. (2014) (22)
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study. (2017) (22)
Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. (2006) (22)
Moving beyond "bridges". (2013) (21)
The association between cognitive function and objective adherence to dietary sodium guidelines in patients with heart failure (2016) (20)
Coronary Flow Velocity and Disturbed Flow Predict Adverse Clinical Outcome After Coronary Angioplasty (2002) (20)
Associations Between Depressive Symptoms and HFpEF-Related Outcomes. (2020) (19)
Effect of renal function on prognosis in chronic heart failure. (2015) (19)
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans (2021) (17)
The physiologic basis for the management of ventricular assist devices (2006) (17)
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review. (2021) (16)
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support (2021) (16)
Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database (2021) (15)
Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction. (2010) (15)
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. (2021) (15)
Management of Patients With Recovered Systolic Function. (2016) (15)
Devices in acute heart failure (2008) (14)
From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure. (2016) (14)
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. (2021) (14)
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association (2022) (14)
Current therapeutic approach in heart failure with preserved ejection fraction. (2014) (14)
Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study. (2011) (14)
Effect of Heart Failure With Preserved Ejection Fraction on Nitric Oxide Metabolites. (2016) (14)
Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis (2020) (13)
Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy (2018) (13)
Cardiovascular Risk Assessment and Management in Prerenal Transplantation Candidates. (2016) (13)
Application of the H2FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial (2019) (13)
Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial (2018) (12)
BIOMARKER PREDICTORS OF CARDIAC HOSPITALIZATION IN CHRONIC HEART FAILURE: A RECURRENT EVENT ANALYSIS (2014) (12)
Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. (2022) (12)
APPLICATION OF THE H2FPEF-SCORE TO A GLOBAL CLINICAL TRIAL OF PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE TOPCAT TRIAL (2019) (12)
Systematic collection of patient-reported outcomes in atrial fibrillation: feasibility and initial results of the Utah mEVAL AF programme. (2019) (12)
Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study (2018) (12)
Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow. (2016) (11)
Frequency and impact of delayed decisions regarding heart transplantation on long-term outcomes in patients with advanced heart failure. (2004) (11)
Update in the approach to and management of heart failure. (2006) (11)
The world post-STICH: is this a "Game Changer?" A non-invasive cardiologist's perspective-revascularization is the treatment of choice only in patients who fail medical therapy. (2013) (10)
Executive Summary of the SCAI/HFSA Clinical Expert Consensus Document on the Use of Invasive Hemodynamics for the Diagnosis and Management of Cardiovascular Disease. (2017) (10)
Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. (2019) (10)
The interventional heart failure initiative: A mission statement for the next generation of invasive cardiologists (2015) (10)
Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder? (2019) (9)
Emergent cesarean section in the catheterization laboratory for spontaneous coronary artery dissection. (2015) (9)
CRT should be reserved for a QRS duration ≥150 ms: pro. (2013) (8)
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function. (2021) (8)
Long-Term Outcomes of Acute Heart Failure: Where Are We Now? (2017) (8)
SUDDEN DEATH IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A COMPETING RISKS ANALYSIS FROM THE TOPCAT TRIAL (2018) (8)
Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support (2021) (8)
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial (2022) (8)
Heart failure therapy: what should clinicians believe? (2012) (8)
Reversal of severe biventricular dysfunction from cardiac hemochromatosis with iron removal. (2013) (7)
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction (2021) (7)
Images in clinical medicine. Necrobiosis lipoidica diabeticorum. (2006) (7)
QRS Duration Criteria to Select Patients for Cardiac Resynchronization Therapy (2013) (7)
Influence of ejection fraction on cause‐specific mortality in heart failure with preserved ejection fraction (2018) (7)
Ventricular Assist Devices and Total Artificial Hearts (2010) (7)
Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials. (2017) (7)
Surgical Management of Congestive Heart Failure (2004) (7)
Heart-Failure Therapy - New Drugs but Old Habits? (2019) (7)
Treating heart failure on dialysis. Finally getting some evidence. (2010) (6)
Diagnosis and treatment of sleep apnea in heart disease (2007) (6)
FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure (2021) (6)
Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? (2015) (6)
Endothelin-1 Is a Key Mediator of Coronary Vasoconstriction in Patients With Transplant Coronary Arteriosclerosis (2009) (6)
Dealing With Unintended Consequences: Continuous-Flow LVADs and Aortic Insufficiency. (2016) (6)
Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. (2020) (6)
Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization (2021) (5)
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial. (2022) (5)
Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HF. (2022) (5)
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction. (2022) (5)
Executive summary of the SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease (2017) (5)
Advanced heart failure: Trans‐Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement (2018) (5)
Patient‐reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program (2020) (5)
Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial (2019) (4)
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (2022) (4)
Heart Failure With a Better Ejection Fraction: Why Should We Care? (2016) (4)
Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary : A Report of the American College of Cardiology 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: (2013) (4)
Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock (2016) (4)
The History and Physical Examination (2012) (4)
Response to letter regarding article, "Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes". (2015) (4)
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study (2021) (4)
Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial (2020) (4)
Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure. (2021) (4)
Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure. (2019) (4)
Goldilocks Dilemma of Dose Titration in Heart Failure With Reduced Ejection Fraction: Too Little, Too Much, or Just Right? (2017) (3)
Quantifying the Impact of Atrial Fibrillation on HF-Related Patient-Reported Outcomes in the Utah mEVAL Program. (2021) (3)
What is the Role of Standard Heart Failure Drug Therapy in the Context of VAD-Induced Unloading of the Failing Human Heart? (2015) (3)
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database (2022) (3)
Recent Advances in Cardiac Allotransplantation (2005) (3)
Structural and Functional Myocardial Improvement Following Continuous-Flow Mechanical Unloading in Chronic Ischemic and Non-Ischemic Cardiomyopathy (2015) (3)
Can a Pulmonary Artery Catheter Improve Outcomes in Cardiogenic Shock? (2020) (3)
Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE‐HF trial (2022) (3)
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER. (2022) (3)
SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges (2020) (3)
Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy. (2010) (3)
Impact of QRS duration on survival benefit with prophylactic implantable cardioverter-defibrillators: a meta-analysis of randomized controlled trials (2015) (3)
The Diastolic Pulmonary Gradient as a Predictor of Adverse Outcomes in Patients With Acute Decompensated Heart Failure (2014) (2)
066 - Real-Time Assessment of Patient Reported Outcomes in Heart Failure Clinic (2017) (2)
Characterization of Sympathetic Innervation in Heart Failure With Preserved Ejection Fraction. (2019) (2)
P2-5: What do patients know about ICDs? (2006) (2)
Pressure Volume System for Management of Heart Failure and Valvular Heart Disease (2019) (2)
Angiotensin-receptor blockade, cancer, and concerns – Authors' reply (2010) (2)
Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosis (2019) (2)
Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant versus Left Ventricular Assist Device: Analysis of a Multicenter, Nationwide Database (2018) (2)
An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure? (2016) (2)
FEASIBILITY AND EFFECTIVENESS OF A SHOCK TEAM APPROACH IN REFRACTORY CARDIOGENIC SHOCK: PRELIMINARY RESULTS (2018) (2)
Pulmonary hypertension in heart failure: measurable, but how meaningful? (2015) (2)
Virtual Outpatient Heart Failure Care - Lessons From the Covid-19 Era (2020) (2)
A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices (2014) (2)
When the VEST Does Not Fit: Representations of Trial Results Deviating From Rigorous Data Interpretation. (2018) (2)
Taking NO for an Answer: Exploring the Therapeutic Potential of Nitrite in HFpEF. (2016) (2)
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. (2022) (2)
INFLUENCE OF LEFT VENTRICULAR EJECTION FRACTION ON CAUSE-SPECIFIC MORTALITY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE TOPCAT TRIAL (2017) (2)
Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. (2019) (2)
Early and Late Right Heart Failure Following LVAD Implantation: Epidemiology, Natural History and Outcomes. An Analysis of the STS INTERMACS Database (2019) (2)
An unusual case of biopsy-negative amyloid cardiomyopathy. (2010) (2)
Cardiac Rotational Mechanics as a Predictor of Favorable Functional and Structural Response After Mechanical Unloading With Cardiac Assist Devices in Advanced Heart Failure Patients (2015) (2)
A Mechanical Bridge to Recovery as a Bridge to Discovery: Learning From Few and Applying to Many. (2022) (2)
Left Ventricular Hemodynamic Changes During Transcatheter Aortic Valve Replacement Assessed by Real-Time Pressure-Volume Loops. (2020) (2)
Utilization and Impact of Right Heart Catheterization on In-hospital Mortality, Length of hospital Stay and 30 Day Readmission in Patients Admitted with Cardiogenic Shock - Review of Large, National, Multicenter Database (2018) (1)
Hemodynamics in Heart Failure (2020) (1)
Late Antibody-Mediated Rejection (AMR) in Heart Transplantation: How “Late” Is It? (2014) (1)
Abstract 2359: Heart Failure Patients Define Threshold for Left Ventricular Assist Devices (2006) (1)
Histologic Features of Mixed Rejection in Heart Transplantation: More Than Just Cellular + Antibody-Mediated Rejection? (2016) (1)
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF. (2023) (1)
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum. (2022) (1)
Reviewers for the Journal, January-June 2016. (2016) (1)
Abstract 2743: Improved Survival for Class III Heart Failure after 2000: Impact of Therapies Demonstrated in a Real-life Population (2006) (1)
Iconography : Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials (2012) (1)
Determinants of Waiting List Time for Heart Transplantation: Is It All About Sensitization? (2014) (1)
Exertional Angina Due To Fused Aortic Bioprosthesis During Left Ventricular Assist Device Support: Two Cases and Review of the Literature. (2017) (1)
Outcomes in Patients with Chronic Kidney Disease and End Stage Renal Disease and Durable Left Ventricular Assist Device: Insights from United States Renal Data System Database. (2022) (1)
Abstract 10595: Health Related Quality of Life as Predictor of Outcomes in Heart Failure (2021) (1)
FEASIBILITY AND EFFECTIVENESS OF A MULTIDISCIPLINARY TEAM APPROACH IN REFRACTORY CARDIOGENIC SHOCK: A PROSPECTIVE PILOT STUDY (2016) (1)
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction (2021) (1)
Heterogeneity Of Early B-type Natriuretic Peptide Change In HFrEF Patients Treated With Sacubitril/Valsartan (2022) (1)
Device Therapy for Heart Failure (2006) (1)
Sex Differences in the Risk of Pump Thrombosis in Patients Supported with Left Ventricular Assist Devices (2018) (1)
Tricuspid Valve Surgery in Right Heart Failure (2005) (1)
EXPRESSION OF CHEMOKINE RECEPTORS IN HUMAN CARDIAC ALLOGRAFTS.: Abstract# 453 Poster Board #‐Session: P93‐II (2000) (1)
At risk for missed diagnosis of heart failure symptoms (2004) (1)
Scientific Statement From the American Heart Association Care Unit and the Emerging Need for New Medical Staffing and Training Models : A Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive (2012) (1)
Who Gets Better With Dilated Cardiomyopathy?: The Evolving Role of Cardiac Magnetic Resonance Imaging. (2021) (1)
High Dose Diuretics in Ambulatory Chronic Heart Failure Patients – Cause or Marker of Instability? (2006) (1)
Tissue is the Issue, Even During a Pandemic. (2020) (1)
Effects of Sacubitril-valsartan Compared with Enalapril on Arterial Hemodynamics, Cardiac Remodeling, and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction (2019) (1)
Left Ventricular Assist Device-Associated Allosensitization - Much More Than a Nuisance (2015) (1)
Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)) (2012) (1)
CARDIAC AND SYSTEMIC INFLAMMATORY BURDEN PREDICTS CARDIAC RECOVERY IN VENTRICULAR ASSIST DEVICE PATIENTS: A PROSPECTIVE STUDY (2019) (1)
Heart failure and diabetes: collateral benefit of chronic disease management? (2003) (0)
SCAI CARDIOGENIC SHOCK CLASSIFICATION SYSTEM TO PREDICT SURVIVAL (2020) (0)
Acute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular Aneurysm. (2017) (0)
TNF as a Predictor of Myocardial Functional Improvement Induced By Left Ventricular Mechanical Unloading (2014) (0)
Grace Under Pressure. (2022) (0)
(909) - Unique Characteristics of Allograft Microvasculature in Patients with Severe Symptomatic Cardiac Allograft Vasculopathy (2017) (0)
The heart–kidney relationship in heart failure: it's not you, it's me (2017) (0)
Abstract 17890: Regional Differences in Cardiac Biomarker Profile and Effect of Spironolactone in Patients With Heart Failure and Preserved Ejection Fraction Enrolled in the TOPCAT Trial (2016) (0)
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. (2023) (0)
Risk of left ventricular systolic dysfunction with sunitinib therapy in patients with metastatic renal cell carcinoma: A prospective cohort study. (2016) (0)
IMPAIRED LIVER FUNCTION IS ASSOCIATED WITH HYPOTENSION AND ELEVATED RIGHT ATRIAL PRESSURE BUT NOT DEPRESSED CARDIAC INDEX IN CHRONIC HEART FAILURE (2023) (0)
Who Is the Target Patient for a Ventricular Assist Device (2006) (0)
Abstract 2098: Clinical Predictors of Hepatic Fibrosis in Chronic Heart Failure (2007) (0)
Predicting Cardiac Recovery before Durable Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients (2019) (0)
From Statistical Significance to Clinical Relevance: A Simple Algorithm to Integrate BNP and the Seattle Heart Failure Model for Risk Stratification in Heart Failure (2016) (0)
Evaluation of a new diagnosis of congestive heart failure (2009) (0)
Structural Remodeling of the Cardiac Ventricles: When Left Isn’t Equally Right (2014) (0)
A Comprehensive Analysis of Trends in Demographics, Interventions and Outcomes Among Patients with Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample Registry Study (2018) (0)
EFFECT OF ANTI-HYPERTENSIVE THERAPY ON THE INCIDENCE OF STROKE IN PATIENTS WITH PREHYPERTENSIVE BLOOD PRESSURE LEVELS: META-ANALYSIS OF PLACEBO CONTROLLED RANDOMIZED TRIALS (2011) (0)
Impact of Donor and Recipient Socio-economic Status (SES) on Outcomes in Adult Heart Transplantation: Does It Really Matter? (2014) (0)
RIGHT VENTRICLE DYSFUNCTION PREDICTS CARDIOGENIC SHOCK IN PATIENTS WITH ACUTE CORONARY SYNDROME (2018) (0)
What Do Heart Failure Patients Think about Research Studies (2006) (0)
Consensus Statement Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research (2013) (0)
Interrupted Time Series Analysis of Donor Heart Utilization Before and After the 2018 UNOS Heart Allocation Policy Change. (2022) (0)
Accelerated transplant vasculopathy portends proliferative restenosis after percutaneous coronary intervention in cardiac transplant patients (2003) (0)
Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: A retrospective cohort study. (2022) (0)
Echocardiographic Patterns of Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction (2019) (0)
Diagnosis and Treatment of Acute Pulmonary Edema (2009) (0)
Abstract 19376: High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure (2010) (0)
Abstract 15516: A Home Care Program Early After Heart Failure Hospitalization Decreases All-Cause 30 Day Readmission Rates (2011) (0)
Acute Decompensated Heart Failure, Volume, and Acetazolamide. (2022) (0)
Reply: Bridging Anticoagulation. (2016) (0)
A Novel Predictive Risk Score for Gastrointestinal Bleed Following Implantation of Continuous Flow Left Ventricular Assist Device (2018) (0)
Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction (2018) (0)
(664) - Outcomes of Asian-Americans Undergoing Left Ventricular Assist Device Implantations as a Bridge to Transplant or Destination Therapy: An INTERMACS Analysis (2017) (0)
Magnetic Resonance Imaging of Cardiac Allografts: What's Next? (2019) (0)
Predictors of Favorable Outcome in Patients Bridged to Transplant with Temporary Mechanical Circulatory Support Devices (2019) (0)
(1214) – Excellent Outcomes After Heart Transplantation in Stable, Highly-Sensitized Heart Transplant Recipients Using a Wait and Match Strategy (2017) (0)
Back to the Future: Circulation Time Revisited. (2016) (0)
Echocardiographic Changes in Heart Failure Patients Treated with Transvenous Stimulation of the Phrenic Nerve for Central Sleep Apnea (2020) (0)
Circulatory Support Devices (2007) (0)
Mixed Cellular and Antibody-Mediated Rejection in Heart Transplantation: A Distinct Entity or Simply the Sum of Two? (2015) (0)
STATE OF ART: ISHLT SUMMARY STATEMENT World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation (2012) (0)
Improving Prediction of Acute Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Devices Using Novel Comprehensive Eighteen-Segment Echocardiographic Strain Analysis (2021) (0)
Abstract 2315: Markedly Enhanced Activity of Endothelin-1 in Transplant Coronary Arteriosclerosis (2007) (0)
Stability of Cardiac Function after Left Ventricular Assist Device Weaning in End-Stage Heart Failure (2019) (0)
Abstract 15813: Impact of QRS Duration on Clinical Event Reduction with Cardiac Resynchronization Therapy: A Meta-Analysis of Randomized Controlled Trials (2010) (0)
Sundaram and Fang Gut and Liver in Heart Failure 1697 Cardiointestinal Syndrome (2016) (0)
Advanced Therapies for Advanced Heart Failure: Time to Raise Awareness. (2016) (0)
A Patient with Chronic Kidney Disease and Heart Failure with Preserved (2019) (0)
EXPRESSION OF CHEMOKINES AND CHEMOKINE RECEPTORS IN HUMAN CARDIAC ALLOGRAFTS: ASSOCIATION WITH CD3+ T CELL INTILTRATES AND REJECTION (1999) (0)
Hemodynamic Profiles in Heart Failure Patients [1] (multiple letters) (2004) (0)
Cardiovascular Issues in Urologic Surgery (2007) (0)
Administrative data: proceed with caution. (2015) (0)
Complement Negative AMR: Does It Confer a Different CV Mortality Risk From Other Categories of AMR? (2015) (0)
Cardiogenic Shock and Short-Term Mechanical Circulatory Support Options in the Current Era: Focus on Adverse Events (2018) (0)
Clinical Importance of Markers of Congestion over Time in Patients with Heart Failure with Preserved Ejection Fraction (2019) (0)
1069-106 Deaths from heart failure in the Era of the implantable defibrillator (2004) (0)
Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization (2014) (0)
Safety and Efficacy of a De-Escalating Dose Regimen of rATG for Induction Therapy in Heart Transplantation: A Single Center Experience.: Abstract# C1602 (2014) (0)
Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties (2016) (0)
Hemodynamic profiles in heart failure: Reply (2004) (0)
Central Sleep Apnea in Heart Failure: Sleeping With the Wrong Enemy? (2017) (0)
Effect of vitamins E and C on transplant-associated atherosclerosis (2002) (0)
Allograft Rejection Surveillance In Heart Transplantation: Is There a Better Way? (2022) (0)
Neuregulin-1β Is Associated with Cardiomyopathy Etiology, Disease Severity, and Adverse Outcomes in Chronic Heart Failure (2009) (0)
B-PO05-200 EJECTION FRACTION IMPROVEMENT DOES NOT REFLECT CHANGES IN HEALTH-RELATED QUALITY OF LIFE FOLLOWING CARDIAC RESYNCHRONIZATION THERAPY (2021) (0)
MYOCARDIAL AND END-ORGAN RESPONSE AFTER LONG-TERM MECHANICAL UNLOADING WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICE: AXIAL- VERSUS CENTRIFUGAL-FLOW (2016) (0)
CLINICAL FRAMEWORK FOR THE STAGING OF REVERSE CARDIAC REMODELING WITH MECHANICAL UNLOADING AND CIRCULATORY SUPPORT (2020) (0)
A Multimarker Panel Improves Risk Prediction in Chronic Heart Failure (2011) (0)
Lower Proportion of Hospitalizations among Non-Homebound Patients Who Received Home Care after Hospital Discharge for Acute Heart Failure Hospitalization (2019) (0)
PREDICTING CARDIAC STRUCTURAL AND FUNCTIONAL IMPROVEMENT INDUCED BY MECHANICAL UNLOADING IN CHRONIC HEART FAILURE: A DERIVATION-VALIDATION MULTICENTER STUDY (2020) (0)
Predicting Right Ventricular Failure Following Left Ventricular Assist Device Support: A Derivation-Validation Multicenter Risk Score (2021) (0)
P2628Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients (2019) (0)
P6508Balance of risk and benefit of spironolactone according to renal function in heart failure patients with preserved ejection fraction (2018) (0)
HEALTH RELATED QUALITY OF LIFE AS PREDICTOR OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
Heart failure disease management: predictors of intensity of care after hospital discharge (2003) (0)
Impact of a Novel Shared Healthcare Delivery Model in Remotely Located Patients with Left Ventricular Assist Devices (2018) (0)
Safety and Efficacy of Late Conversion to Sirolimus Based Immunosuppression, in Heart Transplant Recipients (2008) (0)
Sleep Disordered Breathing in Heart Failure with Preserved Ejection Fraction (2013) (0)
Treating the Cardiorenal Syndrome: A Sledgehammer for a Needle's Work? (2019) (0)
Delayed disease progression is not associated with more clinical compromise (2004) (0)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (0)
CARDIOPULMONARY PRESENTATION OF A PATIENT WITH XXXY SYNDROME (2018) (0)
Multicenter-Derived Clinical Score Predicts Structural and Functional Cardiac Improvement in Chronic Heart Failure Patients Undergoing Mechanical Circulatory Support (2022) (0)
Is routine surveillance biopsy obsolete? A multi-institutional analysis (2005) (0)
Age is not a factor in survival of patients undergoing left ventricular assist device placement as destination therapy: The REMATCH experience (2003) (0)
Predictors and Significance of Decrease in Serum Creatinine in Heart Failure Patients Treated for Volume Overload with Diuretics or Ultrafiltration (2008) (0)
SPHINGOLIPIDS AS POTENTIAL SURROGATES OF MYOCARDIAL RECOVERY IN LEFT VENTRICULAR ASSIST DEVICE PATIENTS (2023) (0)
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions (2022) (0)
Cardiac Reverse Remodeling and Recovery in Dilated Cardiomyopathy Medication-Naive Patients Requiring Durable Left Ventricular Assist Device Support (2019) (0)
Surgical Revascularization in the Management of Heart Failure and Ischemic Left Ventricular Dysfunction (2005) (0)
Functional and Structural Myocardial Improvement after LVAD Therapy: The U-NOVA Reverse Remodeling Stages (2019) (0)
Title: Prognostic value of galectin-3 for adverse outcomes in chronic heart failure Short title: Prognostic value of galectin-3 (2015) (0)
HFpEF Therapy in 2022: What Drugs and Why? (2022) (0)
Advanced Heart Failure (2016) (0)
Erratum: WHO Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult. A consensus statement of the PH council of the ISHLT JHLT 2012 (Journal of Heart and Lung Transplantation (2012) 31:9 (913-933)) (2013) (0)
PREDICTORS OF MORTALITY IN ACUTE CORONARY SYNDROME-RELATED CARDIOGENIC SHOCK REQUIRING SHORT-TERM MECHANICAL CIRCULATORY SUPPORT (2020) (0)
P5419Cardiac reverse remodeling and recovery in dilated cardiomyopathy medication-naive patients requiring durable left ventricular assist device support (2019) (0)
Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices (2016) (0)
Running Title : Mechanisms of SCD in NICM ICD Trials (2017) (0)
Ejection Fraction Improvement Does Not Reflect Changes in Quality of Life Following Cardiac Resynchronization Therapy (2022) (0)
UTAH CARDIAC RECOVERY SCORE EFFECTIVELY PREDICTS MYOCARDIAL RECOVERY IN PATIENTS SUPPORTED WITH DURABLE LEFT VENTRICULAR ASSIST DEVICES (2019) (0)
Cardiac And Inflammatory Biomarkers And New Or Worsening Heart Failure In High-risk Patients With COVID-19 (2022) (0)
Unexpected Etiology of Atypical Chest Pain. (2016) (0)
Changes in the Left Ventricular Ejection Fraction and Natriuretic Peptides in Heart Failure Patients with Moderately Reduced and Preserved Ejection Fraction Treated Following Transvenous Stimulation of the Phrenic Nerve for Central Sleep Apnea (2020) (0)
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging. (2018) (0)
Clinical Investigation Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure (2016) (0)
Amyloidosis Cardiomyopathy Demonstrates Distinct Echocardiographic Patterns Compared to Patients with Heart Failure with Preserved Ejection Fraction (2016) (0)
Reply: does size matter? In search of a physiological definition of myocardial atrophy. (2015) (0)
BLACK RACE ASSOCIATED WITH WORSE OUTCOMES IN AMBULATORY HEART FAILURE-PRESERVED EJECTION FRACTION PATIENTS (2015) (0)
Heart Transplantation is Not the Only Option for Patients with Advanced Heart Failure (2010) (0)
Recovery of Myocardial Capillary Bed (Microvascular) Density Persists in Long Term Follow Up of CAV Patients Treated With Sirolimus (2014) (0)
Twenty-first century heart failure deaths (2004) (0)
Readmission Rates in Patients with Left Ventricular Assist Devices (2016) (0)
Impact of Ejection Fraction on Survival Benefit With Implantable Cardioverter-Defibrillator Therapy (2011) (0)
Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. (2022) (0)
The Impact of Diabetes Mellitus and Glycemia on Myocardial Recovery (2021) (0)
Effect of ACE Inhibitors on the Incidence of Cancer: Meta-Analysis of Randomized Controlled Trials (2010) (0)
Predicting Cardiac Structural And Functional Improvement On Left Ventricular Assist Device Support: The Externally Validated UCAR Score (2022) (0)
Cytokine Expression in the Myocardium Correlates With Cardiac Structural and Functional Improvement Induced By Mechanical Unloading in Chronic Heart Failure (2015) (0)
requency and Impact of Delayed Decisions egarding Heart Transplantation on Long-Term utcomes in Patients With Advanced Heart Failure (2016) (0)
REVISITING A RARE MI COMPLICATION: VENTRICULAR SEPTAL RUPTURE (2020) (0)
n-Stent Restenosis and Remote Coronary Lesion rogression Are Coupled in Cardiac Transplant asculopathy But Not in Native Coronary Artery Disease (2006) (0)
Comprehensive echocardiographic assessment of cardiac function in patients with metastatic renal cell carcinoma newly initiated on sunitinib. (2016) (0)
PATIENT HEALTH STATUS TRAJECTORIES IN HEART FAILURE WITH RECOVERED EJECTION FRACTION (2019) (0)
Effect of Continuous‐Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Non‐Ischemic Cardiomyopathy (2020) (0)
Profiles in cardiomyopathy and heart failure (2013) (0)
POST-HOSPITAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK: FINDINGS FROM THE ACTION REGISTRY-GWTG (2015) (0)
Neuregulin-1 (cid:1) Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure Heart Failure (2009) (0)
Cardiac Metabolism Gene Expression Differences in Patients With Advanced Ischemic Versus Non-Ischemic Cardiomyopathy (2014) (0)
Outcomes of Restrictive Cardiomyopathy Following LVAD Placement: An IMACS Analysis (2020) (0)
Plasma brain injury markers are associated with volume status but not muscle health in heart failure patients (2022) (0)
Myocardial Capillary Loss in Cardiac Allograft Vasculopathy: A Longitudinal Case-Control Study (2016) (0)
Ischemic Coronary Artery Disease (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James Chen-tson Fang?

James Chen-tson Fang is affiliated with the following schools:

Case Western Reserve University
Oregon Health & Science University
University of Utah
Leiden University

James Chen-tson Fang's Academic­Influence.com Rankings

James Chen-tson Fang's Degrees

Why Is James Chen-tson Fang Influential?

James Chen-tson Fang's Published Works

Published Works

What Schools Are Affiliated With James Chen-tson Fang?

James Chen-tson Fang's AcademicInfluence.com Rankings